pharmaceuticals

The futures are flat on this Thanksgiving eve as trading volume will slow to a trickle with the holiday tomorrow and an early 1 pm EST close for Friday. The major indices all ended Tuesday higher...
The futures are trading lower as we start the Thanksgiving holiday-shortened trading week. The stock market is closed on the big turkey day, and will also shutter  early at 1 pm EST on Black Friday....
Maryland is one of five states in which voters will have a chance to decide in November whether or not to legalize marijuana.
Colorado residents have the opportunity to vote on the decriminalization of psilocybin and other psychedelics on November 8.
These five companies are on deck to report earnings before markets open Thursday morning.
Here are previews of three pharmaceutical giants set to report earnings before markets open on Friday.
A recent survey of global fund managers found that many have turned to health care for some stability in these uncertain times. These eight high-dividend-paying stocks are rated Buy at top Wall...
Here are a few big biopharma names on which Wall Street is growing more bearish.
A few big biopharma names were on the move Tuesday morning, and analysts were taking their shot at them.
A recent analysis reveals that a drug discount program can save consumers up to $6,100 off the retail price.
Here is a look of a few of the biggest clinical trial and FDA updates in regards to psychedelics to watch for in 2022.
Shares of five top established and mature biotechnology and pharmaceutical companies have been hit hard and are offering some of the best entry points in months. The stocks also are rated Buy at top...
With the potential for far lower returns in the coming year, total return becomes a key ingredient for investment success. These five top health care stocks look like very solid ideas for 2022, as...
Current shortages in the goods people normally buy extend to these 100+ medications.
In this massively overbought market, health care stocks could benefit from a shift toward more defensive sectors. These five offer strong balance sheets, attractive dividend yields and improved cost...